BriaCell Therapeutics Corp

NAS:BCTXHealthcarenasdaq_composite

$3.35−1.76%LiveIn session · ≈ AED 12.30 · Market cap $29.14M

BCTX · Balance sheet · TradingHolo

Reported currency millions	FY2020 · CAD	FY2021 · USD	FY2022 · USD	FY2023 · USD	FY2024 · USD	FY2025 · USD	YoY
Cash & cash equivalents	0.0	71.6	52.6	28.4	1.2	14.4	+1105.6%
Cash & short-term investments	0.0	71.6	52.6	28.4	1.2	24.6	+1952.6%
Receivables	0.0	0.0	0.0	1.0	1.9	0.8	−59.1%
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	—
Total current assets	0.3	72.2	54.3	36.0	5.1	27.4	+440.1%
Property, plant & equipment	0.0	0.0	0.0	0.0	0.5	0.4	−24.3%
Goodwill & intangibles	0.3	0.3	0.3	0.3	0.3	0.3	−8.5%
Long-term investments	0.0	0.0	0.0	0.0	0.6	0.7	+24.1%
Total assets	0.5	72.5	54.6	36.3	8.2	29.8	+265.1%
Payables	0.0	0.3	0.6	1.5	10.0	4.5	−54.6%
Short-term debt	0.2	0.0	0.0	0.0	0.0	0.0	—
Total current liabilities	4.0	0.7	1.2	2.4	10.4	5.5	−47.2%
Long-term debt	0.0	0.0	0.0	0.0	0.0	0.0	—
Total debt	0.2	0.0	0.0	0.0	0.0	0.0	—
Net debt	0.2	(71.5)	(52.6)	(28.4)	(1.2)	(14.4)	−1105.6%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	4.1	38.0	41.4	41.3	11.9	5.9	−50.1%
Total equity	(3.6)	34.6	13.2	(5.0)	(3.3)	24.6	+843.3%
Retained earnings	(18.2)	(36.4)	(77.4)	(107.7)	(118.6)	(153.7)	−29.5%

Reported currency millionsUpdated Tue 9 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

Reporting currencies differ or are unavailable; each column identifies its currency.